Arctic Bioscience AS (OSL:ABS)

Arctic Bioscience AS Statistics

Total Valuation

OSL:ABS has a market cap or net worth of NOK 101.26 million. The enterprise value is 153.93 million.

Market Cap	101.26M
Enterprise Value	153.93M

Important Dates

The last earnings date was Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

OSL:ABS has 26.86 million shares outstanding. The number of shares has increased by 2.95% in one year.

Current Share Class	26.86M
Shares Outstanding	26.86M
Shares Change (YoY)	+2.95%
Shares Change (QoQ)	+4.90%
Owned by Insiders (%)	17.94%
Owned by Institutions (%)	15.77%
Float	12.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.21
PB Ratio	0.52
P/TBV Ratio	0.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.55
EV / Sales	3.35
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-2.63

Financial Position

The company has a current ratio of 0.83, with a Debt / Equity ratio of 0.28.

Current Ratio	0.83
Quick Ratio	0.34
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	-0.94
Interest Coverage	-6.86

Financial Efficiency

Return on equity (ROE) is -20.15% and return on invested capital (ROIC) is -10.20%.

Return on Equity (ROE)	-20.15%
Return on Assets (ROA)	-8.82%
Return on Invested Capital (ROIC)	-10.20%
Return on Capital Employed (ROCE)	-17.80%
Revenue Per Employee	2.09M
Profits Per Employee	-1.97M
Employee Count	22
Asset Turnover	0.16
Inventory Turnover	1.00

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -69.83% in the last 52 weeks. The beta is 1.32, so OSL:ABS's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	-69.83%
50-Day Moving Average	3.75
200-Day Moving Average	3.43
Relative Strength Index (RSI)	48.32
Average Volume (20 Days)	172,217

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OSL:ABS had revenue of NOK 45.90 million and -43.36 million in losses. Loss per share was -1.66.

Revenue	45.90M
Gross Profit	14.44M
Operating Income	-39.78M
Pretax Income	-43.36M
Net Income	-43.36M
EBITDA	-38.03M
EBIT	-39.78M
Loss Per Share	-1.66

Balance Sheet

The company has 2.49 million in cash and 55.16 million in debt, giving a net cash position of -52.67 million or -1.96 per share.

Cash & Cash Equivalents	2.49M
Total Debt	55.16M
Net Cash	-52.67M
Net Cash Per Share	-1.96
Equity (Book Value)	195.30M
Book Value Per Share	7.27
Working Capital	-11.63M

Cash Flow

In the last 12 months, operating cash flow was -41.27 million and capital expenditures -17.16 million, giving a free cash flow of -58.42 million.

Operating Cash Flow	-41.27M
Capital Expenditures	-17.16M
Free Cash Flow	-58.42M
FCF Per Share	-2.18

Margins

Gross margin is 31.45%, with operating and profit margins of -86.68% and -94.48%.

Gross Margin	31.45%
Operating Margin	-86.68%
Pretax Margin	-94.48%
Profit Margin	-94.48%
EBITDA Margin	-82.87%
EBIT Margin	-86.68%
FCF Margin	n/a

Dividends & Yields

OSL:ABS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.95%
Shareholder Yield	n/a
Earnings Yield	-42.82%
FCF Yield	-57.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3